Bharat Biotech Fact sheet
2
Bharat Biotech Manufacturing and R&D Facilities is a multidimensional product-oriented biotechnology company specializing in development and manufacturing of vaccines and biotherapeutics. With a mantra of Lead Innovation, the company develops next-generation vaccines and bio-therapeutics, focused around public health of the developing nations. Bharat Biotech is the first bio-pharma facility in India to be audited and approved by Korean Food & Drugs Administration (KFDA). Bharat Biotech supplies both bio-therapeutics to Central Government under National Immunization Program (NIP), several other State Government’s and to over 65 countries worldwide. Bharat Biotech’s manufacturing plant spreading across a picturesque campus, located at Genome valley, is one of the largest of its kind in Asia- Pacific. With an investment over INR 1000 Mn, the facility's manufacturing, control procedures and protocols conform to stringent standards, having been audited by WHO, KFDA, ANVISA, INVIMA & regulatory authorities of various other countries. Bharat Biotech has set new benchmarks in innovation and quality that epitomizes the tremendous progress of Indian biotechnology in the global arena. vaccines and Corporate Fact Sheet Dr. Krishna M. Ella Bharat Biotech Chairman & Managing Director “Our mission is to address the health care needs of emerging markets, drive innovation, be a front runner in research and development of new vaccines and bio-therapeutics” Mission 7 Billion Vision To offer affordable, safe and effective healthcare solutions to combat mankind's most dreaded illnesses and to thus eradicate or at least control their occurrence in the years to come. Mission Developing next-generation remedies through Genetic Engineering Technologies so as to create a healthier world. www.bharatbiotech.com
-
Upload
jenniferclark545 -
Category
Health & Medicine
-
view
10 -
download
0
Transcript of Bharat Biotech Fact sheet
Bharat Biotech
Manufacturing and R&D Facilities
is a multidimensional product-oriented biotechnology company specializing in development and manufacturing of vaccines and biotherapeutics. With a mantra of Lead Innovation, the company develops next-generation vaccines and bio-therapeutics, focused around public health of the developing nations. Bharat Biotech is the first bio-pharma facility in India to be audited and approved by Korean Food & Drugs Administration (KFDA).
Bharat Biotech supplies both bio-therapeutics to Central Government under National Immunization Program (NIP), several other State Government’s and to over 65 countries worldwide.
Bharat Biotech’s manufacturing plant spreading across a picturesque campus, located at Genome valley, is one of the largest of its kind in Asia-Pacific. With an investment over INR 1000 Mn, the facility's manufacturing, control procedures and protocols conform to stringent standards, having been audited by WHO, KFDA, ANVISA, INVIMA & regulatory authorities of various other countries.
Bharat Biotech has set new benchmarks in innovation and quality that epitomizes the tremendous progress of Indian biotechnology in the global arena.
vaccines and
Corporate Fact Sheet
Dr. Krishna M. Ella
Bharat Biotech Chairman & Managing Director
“Our mission is to address the health care needs of emerging markets, drive
innovation, be a front runner inresearch and development of new
vaccines and bio-therapeutics”
Mission7 Billion
Vision
To offer affordable, safe and effective healthcare solutions to combat mankind's most dreaded illnesses and to thus eradicate or at least control their occurrence in the years to come.
Mission
Developing next-generation remedies through G enet ic Engineering Technologies so as to create a healthier world.
www.bharatbiotech.com
Lead Innovation
R&D Focus
R&D Pipeline
Strategy
Bharat Biotech’s goal is to Lead Innovation in research and development of region specific infectious diseases, as well as introduce novel vaccines to solve public health problems affecting the 7 Billion emerging market populace. Bharat Biotech has delivered over 2 billion doses of vaccines in over 65 countries which include Global Health Agencies as well as NH programs. Also, it continues to invest aggressively in R&D with 50 product patent portfolio’s.
Bharat Biotech undertakes transnational research in the area of Molecular Biology, Microbiology, Virology, Immunology, Biochemistry, Clinical Research and Industrial Biotechnology. The company has received grants from Gates Foundation, PATH, DBT, Govt. of India and World Bank for various R&D projects. The company also has alliance with AIIMS, CDC, NIV, NIH, NIA and IISc. The company follows stringent IP regime and has received more than 50 patents till date for various innovative products.
Japanese Encephalitis (JE) MRSA anti infectivesChikungunya RotavirusMalaria HPVVi Typhoid Conjugate
Bharat Biotech’s strategy stems from the philosophy that today’s neglected disease of developing countries will become tomorrows global disease and hence the company wants to combat and reduce the disease burden of the developing countries, by enabling affordable vaccines and bio-therapeutic products, through translational R&D and stringent manufacturing process.
Biovet Private Limited Innova Agri Bio Park Ltd. Century Biologicals Pvt. Ltd.
Other Ventures
www.bharatbiotech.com
Contact information
Genome Valley, Hyderabad - 500 078. A.P. India.Tel.: +91 40 2348 0567 Fax: +91 40 2348 [email protected]
+91 99480 80567
www.bharatbiotech.com
Vaccines
Bio-therapeutics
India’s First Preservative FreeHepatitis-B Vaccine
mcf
INDIRABChromatographically PurifiedVero Cell Rabies Vaccine
World’s First Cesium Chloride FreeHepatitis-B Vaccine
New Generation Vi PolysaccharideTyphoid Vaccine
Human Inactivated Influenza A (H1N1)Virus Vaccine (Adsorbed)
New Generation Vi PolysaccharideTyphoid Vaccine
-PFS
Pentavalent Combination Vaccine
Com ac5
Pentavalent Combination Vaccine
Com ac5-PFS
India’s First HaemophilusType b Vaccine
BioHib
Monovalent Oral Polio Vaccine, Type 1BIOPOLIO M1
Monovalent PoliomyelitisVaccine Type 3, Live (Oral)
BIOPOLIO M3
Com ac4-HBTetravalent Combination Vaccine
Bivalent Poliomyelitis Vaccine Type 1&3, Live (Oral)BIOPOLIO B1/3
Com ac3Trivalent Combination Vaccine
Trivalent Oral Polio Vaccine
BIOPOLIO
HEPASOLVHeparin Sodium Injection
India’s First Recombinant Human Epidermal GrowthFactor for I & II Degree Burns and Skin Grafts
India’s First Probiotic Yeast
Low Molecular Weight Heparin EnoxaparinSodium Injection
Zinc with ORS
India’s First Recombinant Human Epidermal GrowthFactor for Diabetic Foot Ulcers
Recombinant Human Epidermal Growth Factor,Silver Sulfadiazine & Chlorhexidine GluconateCream
